respiratory
Asthma

Asthma biologic PBS listed for children


A biologic medicine to treat severe allergic asthma in patients whose symptoms are inadequately controlled on high dose preventer medications is now available to children age six and over on the PBS. Novartis’ Xolair® (omalizumab) is a humanised monoclonal antibody for subcutaneous injection that selectively binds to immunoglobulin E (IgE), blocking the allergic cascade and ...

Already a member?

Enter your email to keep reading.


OR